Raised plasma aldosterone and natriuretic peptides in atrial fibrillation

TY - JOUR

T1 - Raised plasma aldosterone and natriuretic peptides in atrial fibrillation

AU - Dixen, U

AU - Ravn, L

AU - Soeby-Rasmussen, C

AU - Paulsen, AW

AU - Parner, J

AU - Frandsen, E

AU - Jensen, Gorm B

AU - Dixen, Ulrik

AU - Ravn, Lasse Steen

AU - Soeby-Rasmussen, Christian

AU - Paulsen, Anders Wallin

AU - Parner, Jan

AU - Frandsen, Erik

N1 - Copyright 2007 S. Karger AG, Basel.

PY - 2007

Y1 - 2007

N2 - During atrial fibrillation (AF), the renin-angiotensin-aldosterone system (RAAS) may be activated. In this study, our aim was to evaluate at a long-term follow-up visit the levels of plasma aldosterone and natriuretic peptides as markers of neurohormonal remodeling in patients with earlier, documented AF in relation to present heart rhythm, clinical data, and the left ventricular ejection fraction (LVEF). We hypothesized that increased levels of aldosterone and natriuretic peptides were significantly associated with present AF as markers of RAAS activation during the arrhythmia.

AB - During atrial fibrillation (AF), the renin-angiotensin-aldosterone system (RAAS) may be activated. In this study, our aim was to evaluate at a long-term follow-up visit the levels of plasma aldosterone and natriuretic peptides as markers of neurohormonal remodeling in patients with earlier, documented AF in relation to present heart rhythm, clinical data, and the left ventricular ejection fraction (LVEF). We hypothesized that increased levels of aldosterone and natriuretic peptides were significantly associated with present AF as markers of RAAS activation during the arrhythmia.

U2 - 10.1159/000095671

DO - 10.1159/000095671

M3 - Journal article

SN - 0008-6312

VL - 108

SP - 35

EP - 39

JO - Cardiology

JF - Cardiology

IS - 1

ER -